HomeLatest NewsCovid-19FDA Alerts Providers to COVID-19 Rapid Test Recall

FDA Alerts Providers to COVID-19 Rapid Test Recall

The Food and Drug Administration announced a Class 1 recall of the E25Bio COVID-19 Direct Antigen Response Test. E25Bio is recalling its COVID-19 Direct Antigen Response Tests (DART) for several reasons, particularly that these tests were marketed and distributed to U.S. customers without authorization, clearance, or approval from the FDA. Labeling distributed with some of the tests also includes inaccurate claims and instructions, including a statement that misrepresents the test as FDA-authorized.

Due to the potential for false results, the FDA said health care providers who administered the test in the past two weeks and suspect an inaccurate result should consider retesting patients with an authorized test.

Click here for further details.

Stay Connected

Unified Voice Newsletter

Events This Month

june

08jun12:00 pm1:00 pmNursing Services Condition of ParticipationSDAHO Webinar

13jun12:00 pm1:00 pmAchieving Clinical Workforce Stability in the New NormalAHA Webinar

14jun10:00 am11:00 amThe Medicare "Must Knows" and Updates for Home HealthSDAHO Webinar

14jun12:00 pm1:00 pmBuprenorphine & its Efficacy for Patients with Serious Illness and End of Life Care SituationsSDAHO Webinar

14jun2:00 pm3:00 pmThe Medicare "Must Knows" and Updates for HospiceSDAHO Webinar


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact